arrow
P

Paola Gallì

lecco
H指数:31
被引数:3,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)

人类免疫缺陷病毒感染者(HIV感染者)未接受SARS-CoV-2疫苗追加加强针的影响因素:一项基于罗马(意大利)行为学和流行病学调查的观察性研究

2025-11-060
OAAI
Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital

在连续的大流行浪潮中,Anti-SARS-CoV-2疫苗接种对新型冠状病毒肺炎住院患者的疾病严重程度和临床结局的影响: 来自意大利参考医院的数据

2024-09-062
OAAI
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

根据先前的天花疫苗暴露和HIV感染,改良安卡拉痘苗暴露前疫苗的免疫原性和反应原性: 前瞻性队列研究

2024-02-018
OAAI
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

风险意识是意大利地区Mpox疫苗接种运动中早期疫苗接种的关键决定因素: 横断面分析

2023-11-273
OAAI
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
2022-08-2271
OAAI
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
2022-04-02103
OAAI
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination

先前的流感和肺炎疫苗对SARS-CoV-2 BNT162b2疫苗接种的体液和细胞反应的影响

2021-06-0816
OAAI